动态适形弧治疗用于肺癌的剂量学研究
该研究在35例肺癌患者中比较动态适形弧治疗(DCAT)与常规三维适形放疗(3D CRT)的剂量学参数,并用放射变色胶片在体模中验证剂量分布一致性。DCAT在计划与实测剂量一致性上不劣于3D CRT,在PTV适形度和机器跳数上显著更优,但在剂量均匀性、平均肺剂量和肺V5Gy上显著更差。作者仅推荐DCAT作为3D CRT的补充技术。
要点
- DCAT计划与实测剂量的一致性等于或优于3D CRT。
- DCAT的PTV适形度和每计划机器跳数显著优于3D CRT。
- DCAT的剂量均匀性、平均肺剂量和肺V5Gy显著差于3D CRT。
核心结论
- 就计划与照射剂量分布的一致性而言,DCAT至少与3D CRT一样可靠。
- 在特定患者解剖和治疗处方条件下,DCAT可能获得更有利的剂量学参数。
- 平均而言常规3D CRT通常获得更好的剂量学参数,故仅推荐DCAT作为3D CRT的补充技术。
研究设计与样本
- 在35例肺癌患者队列中比较DCAT与3D CRT治疗计划的剂量学参数。
- 使用放射变色胶片在拟人模体中比较DCAT和3D CRT的剂量分布与计划值。
主要发现
- 与3D CRT相比,DCAT计划计算剂量与胶片实测剂量的一致性相等或更优。
- DCAT在PTV剂量适形度和每计划机器跳数上显著优于3D CRT。
- DCAT在剂量均匀性、平均肺剂量和肺V5Gy上显著差于3D CRT。
- 肺V20Gy、脊髓1 cm3剂量和食管平均剂量在两种技术间无显著差异。
- V20Gy与V5Gy的改善呈负相关,DCAT计划中靶区体积球形度与剂量均匀性呈中度负相关。
关键数值与推荐
- DCAT与3D CRT在肺V20Gy、脊髓1 cm3剂量和食管平均剂量上无显著差异。
临床怎么用
- DCAT可作为无逆向计划条件科室的补充技术,用于需缩短治疗时间的肺癌患者。
- 选择DCAT时需权衡其适形度和机器跳数优势与剂量均匀性及肺低剂量照射的不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer patients are often in poor physical condition, and a shorter treatment time would reduce their discomfort. Dynamic conformal arc therapy (DCAT) offers a shorter treatment time than conventional 3D conformal radiotherapy (3D CRT) and is usually available even in departments without inverse planning possibilities. We examined its suitability as a treatment modality for lung cancer patients. METHODS: On a cohort of 35 lung cancer patients, relevant dosimetric parameters were compared in respective DCAT and 3D CRT treatment plans. Radiochromic film dosimetry in an anthropomorphic phantom was used to compare both DCAT and 3D CRT dose distributions against their planned counterparts. RESULTS: In comparison with their 3D CRT counterparts, DCAT plans equal or exceed the agreement between the calculated dose and the dose measured using film dosimetry. In dosimetric comparison, DCAT performed significantly better than 3D CRT in dose conformity to PTV and the number of monitor units used per plan, and significantly worse in dose homogeneity, mean lung dose and lung volume exposed to 5 Gy or more (V5Gy). No significant difference was found in the V20Gy value to lung, dose to 1 cm3 of spinal cord, and the mean dose to oesophagus. Improvements in V20Gy and V5Gy were found to be negatively correlated. DCAT plans differ from 3D CRT by exhibiting a moderate negative correlation between target volume sphericity and dose homogeneity. CONCLUSIONS: With respect to the agreement between the planned and the irradiated dose distribution, DCAT appears at least as reliable as 3D CRT. In specific conditions concerning the patient anatomy and treatment prescription, DCAT may yield more favourable dosimetric parameters. On average, however, conventional 3D CRT usually obtains better dosimetric parameters. We can thus only recommend DCAT as a complementary technique to the conventional 3D CRT.
引用
- Peterlin P, Stanič K, Méndez I, et al. Treating lung cancer with dynamic conformal arc therapy: a dosimetric study. Radiat Oncol. 2017. PMID: 28578699. doi:10.1186/s13014-017-0823-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。